The tool reduces pathologist variability in liver biopsy assessment during trials of treatments for metabolic ...

(Image Credits: Pixabay) Fatty liver disease, medically known as hepatic steatosis ... liver without much inflammation or liver cell damage. Non-Alcoholic Steatohepatitis (NASH): Fatty liver ...

Discover preclinical studies that indicate that empagliflozin reduces liver fat, improves liver function markers, and decreases inflammation.

PathAI, a global leader in AI-powered pathology, today announced that the European Medicines Agency (EMA) Committee for ...

The liver is the body’s chemical factory, where most metabolic processes take place. It processes everything you eat and drink, converting them into energy and essential nutrients. Additionally, the ...

According to Cleveland Clinic, “steatosis” is a term healthcare ... In the case of NASH, fat buildup progresses to inflammation, then tissue damage and scarring (fibrosis).

which demonstrated non-inferiority for the features of fibrosis grading and steatosis grade and superiority for lobular inflammation and hepatocellular ballooning. This qualification signifies a ...